An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Clinical trial NCT02529930 · COMPLETED

Trial details

NCT number: NCT02529930
Sponsor: Nykode Therapeutics ASA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

High Grade Cervical Intraepithelial Neoplasia

Start date: 2015-08-01
Primary completion: 2019-01-31
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.